AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
QUALITY-OF-LIFE IN ADVANCED PROSTATE-CANCER - RESULTS OF A RANDOMIZEDTHERAPEUTIC TRIAL
Authors: MOINPOUR CM SAVAGE MJ TROXEL A LOVATO LC EISENBERGER M VEITH RW HIGGINS B SKEEL R YEE M BLUMENSTEIN BA CRAWFORD ED MEYSKENS FL
Citation: Cm. Moinpour et al., QUALITY-OF-LIFE IN ADVANCED PROSTATE-CANCER - RESULTS OF A RANDOMIZEDTHERAPEUTIC TRIAL, Journal of the National Cancer Institute, 90(20), 1998, pp. 1537-1544
SERUM PERCENT FREE PROSTATE-SPECIFIC ANTIGEN IN METASTATIC PROSTATE-CANCER
Authors: LIN DW NOTEBOOM JL BLUMENSTEIN BA ELLIS WJ LANGE PH VESSELLA RL
Citation: Dw. Lin et al., SERUM PERCENT FREE PROSTATE-SPECIFIC ANTIGEN IN METASTATIC PROSTATE-CANCER, Urology, 52(3), 1998, pp. 366-371
BILATERAL ORCHIECTOMY WITH OR WITHOUT FLUTAMIDE FOR METASTATIC PROSTATE-CANCER
Authors: EISENBERGER MA BLUMENSTEIN BA CRAWFORD ED MILLER G MCLEOD DG LOEHRER PJ WILDING G SEARS K CULKIN DJ THOMPSON IM BUESCHEN AJ LOWE BA
Citation: Ma. Eisenberger et al., BILATERAL ORCHIECTOMY WITH OR WITHOUT FLUTAMIDE FOR METASTATIC PROSTATE-CANCER, The New England journal of medicine, 339(15), 1998, pp. 1036-1042
MULTICENTER RT-PCR-PSA CLINICAL-TRIAL FOR PREOPERATIVE STAGING OF PROSTATE-CANCER
Authors: VESSELLA RL LANGE PH BLUMENSTEIN BA GOMELLA LG MORENO JG WOOD DP BEAMAN A MOUL JW SRIVASTAVA S SLAWIN KM SCARDINO PT BUTTYAN R KATZ AE OLSSON CA HESTON WDW FAIR WR OHARA SM VELTRI RW
Citation: Rl. Vessella et al., MULTICENTER RT-PCR-PSA CLINICAL-TRIAL FOR PREOPERATIVE STAGING OF PROSTATE-CANCER, The Journal of urology, 159(5), 1998, pp. 1124-1124
CLINICAL-EVALUATION OF THE BTA TRAK ASSAY AND COMPARISON TO VOIDED URINE CYTOLOGY AND THE BARD BTA TEST IN PATIENTS WITH RECURRENT BLADDER-TUMORS
Authors: ELLIS WJ BLUMENSTEIN BA ISHAK LM ENFIELD DL
Citation: Wj. Ellis et al., CLINICAL-EVALUATION OF THE BTA TRAK ASSAY AND COMPARISON TO VOIDED URINE CYTOLOGY AND THE BARD BTA TEST IN PATIENTS WITH RECURRENT BLADDER-TUMORS, Urology, 50(6), 1997, pp. 882-887
PROPOSED SUBSTAGES FOR METASTATIC PROSTATE-CANCER
Authors: CRAWFORD ED BLUMENSTEIN BA
Citation: Ed. Crawford et Ba. Blumenstein, PROPOSED SUBSTAGES FOR METASTATIC PROSTATE-CANCER, Urology, 50(6), 1997, pp. 1027-1028
IMPROVED DETECTION OF RECURRENT BLADDER-CANCER USING THE BARD BTA STAT TEST
Authors: SAROSDY MF HUDSON MA ELLIS WJ SOLOWAY MS WHITE RD SHEINFELD J JAROWENKO MV SCHELLHAMMER PF SCHERVISH EW PATEL JV CHODAK GW LAMM DL JOHNSON RD HENDERSON M ADAMS G BLUMENSTEIN BA THOELKE KR PFALZGRAF RD MURCHISON HA BRUNELLE SL
Citation: Mf. Sarosdy et al., IMPROVED DETECTION OF RECURRENT BLADDER-CANCER USING THE BARD BTA STAT TEST, Urology, 50(3), 1997, pp. 349-353
COMPARISON OF THE BARD BTA TEST WITH VOIDED URINE AND BLADDER WASH CYTOLOGY IN THE DIAGNOSIS AND MANAGEMENT OF CANCER OF THE BLADDER
Authors: LEYH H HALL R MAZEMAN E BLUMENSTEIN BA
Citation: H. Leyh et al., COMPARISON OF THE BARD BTA TEST WITH VOIDED URINE AND BLADDER WASH CYTOLOGY IN THE DIAGNOSIS AND MANAGEMENT OF CANCER OF THE BLADDER, Urology, 50(1), 1997, pp. 49-53
PHASE-II STUDIES ON PROSTATE-CANCER
Authors: SCHRODER FH NORMING U BLUMENSTEIN BA BUSCH C VANGLABBEKE M HOISAETER PA JOHANSSON JE TRIBUKAIT B
Citation: Fh. Schroder et al., PHASE-II STUDIES ON PROSTATE-CANCER, Urology, 49(4A), 1997, pp. 3-14
TEMPORAL TRENDS IN RATES OF PROSTATE-CANCER - DECLINING INCIDENCE OF ADVANCED-STAGE DISEASE, 1974 TO 1994
Authors: NEWCOMER LM STANFORD JL BLUMENSTEIN BA BRAWER MK
Citation: Lm. Newcomer et al., TEMPORAL TRENDS IN RATES OF PROSTATE-CANCER - DECLINING INCIDENCE OF ADVANCED-STAGE DISEASE, 1974 TO 1994, The Journal of urology, 158(4), 1997, pp. 1427-1430
POLYMORPHIC REPEATS IN THE ANDROGEN RECEPTOR GENE - MOLECULAR MARKERSOF PROSTATE-CANCER RISK
Authors: STANFORD JL JUST JJ GIBBS M WICKLUND KG NEAL CL BLUMENSTEIN BA OSTRANDER EA
Citation: Jl. Stanford et al., POLYMORPHIC REPEATS IN THE ANDROGEN RECEPTOR GENE - MOLECULAR MARKERSOF PROSTATE-CANCER RISK, Cancer research, 57(6), 1997, pp. 1194-1198
OPTIMIZED MICROVESSEL DENSITY ANALYSIS IMPROVES PREDICTION OF CANCER STAGE FROM PROSTATE NEEDLE BIOPSIES
Authors: BOSTWICK DG WHEELER TM BLUTE M BARRETT DM MACLENNAN GT SEBO TJ SCARDINO PT HUMPHREY PA HUDSON MA FRADET Y MILLER GJ CRAWFORD ED BLUMENSTEIN BA MAHRAN HE MILES BJ
Citation: Dg. Bostwick et al., OPTIMIZED MICROVESSEL DENSITY ANALYSIS IMPROVES PREDICTION OF CANCER STAGE FROM PROSTATE NEEDLE BIOPSIES, Urology, 48(1), 1996, pp. 47-57
A COMBINED ANALYSIS OF ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER, AND MEDICAL-RESEARCH-COUNCIL RANDOMIZED CLINICAL-TRIALS FOR THE PROPHYLACTIC TREATMENT OF STAGE TAT1 BLADDER-CANCER - EDITORIAL COMMENT
Authors: BLUMENSTEIN BA
Citation: Ba. Blumenstein, A COMBINED ANALYSIS OF ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER, AND MEDICAL-RESEARCH-COUNCIL RANDOMIZED CLINICAL-TRIALS FOR THE PROPHYLACTIC TREATMENT OF STAGE TAT1 BLADDER-CANCER - EDITORIAL COMMENT, The Journal of urology, 156(6), 1996, pp. 1940-1941
A PHASE-II TRIAL OF INTERFERON-ALPHA AND 5-FLUOROURACIL IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: ELIAS L BLUMENSTEIN BA KISH J FLANIGAN RC WADE JL LOWE BA GOODWIN JW CRAWFORD ED
Citation: L. Elias et al., A PHASE-II TRIAL OF INTERFERON-ALPHA AND 5-FLUOROURACIL IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Cancer, 78(5), 1996, pp. 1085-1088
MEDICAL-RESEARCH DATA
Authors: BLUMENSTEIN BA
Citation: Ba. Blumenstein, MEDICAL-RESEARCH DATA, Controlled clinical trials, 16(6), 1995, pp. 453-454
FUNCTIONS AND ORGANIZATION OF COORDINATING CENTERS FOR MULTICENTER STUDIES
Authors: BLUMENSTEIN BA JAMES KE LIND BK MITCHELL HE
Citation: Ba. Blumenstein et al., FUNCTIONS AND ORGANIZATION OF COORDINATING CENTERS FOR MULTICENTER STUDIES, Controlled clinical trials, 16(2), 1995, pp. 4-29
MAXIMUM ANDROGEN BLOCKADE IN ADVANCED PROSTATE-CANCER - AN OVERVIEW OF 22 RANDOMIZED TRIALS WITH 3283 DEATHS IN 5710 PATIENTS
Authors: DALESIO O VANTINTEREN H DENIS L SCHRODER FH BLUMENSTEIN BA GODWIN J PETO R
Citation: O. Dalesio et al., MAXIMUM ANDROGEN BLOCKADE IN ADVANCED PROSTATE-CANCER - AN OVERVIEW OF 22 RANDOMIZED TRIALS WITH 3283 DEATHS IN 5710 PATIENTS, Lancet, 346(8970), 1995, pp. 265-269
RESULTS OF A MULTICENTER TRIAL USING THE BTA TEST TO MONITOR FOR AND DIAGNOSE RECURRENT BLADDER-CANCER
Authors: SAROSDY MF WHITE RWD SOLOWAY MS SHEINFELD J HUDSON MA SCHELLHAMMER PF JAROWENKO MV ADAMS G BLUMENSTEIN BA
Citation: Mf. Sarosdy et al., RESULTS OF A MULTICENTER TRIAL USING THE BTA TEST TO MONITOR FOR AND DIAGNOSE RECURRENT BLADDER-CANCER, The Journal of urology, 154(2), 1995, pp. 379-383
RESULTS OF A MULTICENTER TRIAL USING THE BTA TEST TO MONITOR FOR AND DIAGNOSE RECURRENT BLADDER-CANCER - REPLY
Authors: SAROSDY MF WHITE RWD SOLOWAY MS SHEINFELD J HUDSON MA SCHELLHAMMER PF JAROWENKO MV ADAMS G BLUMENSTEIN BA
Citation: Mf. Sarosdy et al., RESULTS OF A MULTICENTER TRIAL USING THE BTA TEST TO MONITOR FOR AND DIAGNOSE RECURRENT BLADDER-CANCER - REPLY, The Journal of urology, 154(2), 1995, pp. 384-384
SERUM BASIC FIBROBLAST GROWTH-FACTOR IN MEN WITH AND WITHOUT PROSTATECARCINOMA
Authors: MEYER GE YU EY SIEGAL JA PETTEWAY JC BLUMENSTEIN BA BRAWER MK
Citation: Ge. Meyer et al., SERUM BASIC FIBROBLAST GROWTH-FACTOR IN MEN WITH AND WITHOUT PROSTATECARCINOMA, Cancer, 76(11), 1995, pp. 2304-2311
FATTY-ACIDS AND BREAST-CANCER - IS THERE AN ASSOCIATION
Authors: STANFORD JL KING IB MALONE KE VOIGT LF DALING JR BLUMENSTEIN BA GARRY MR
Citation: Jl. Stanford et al., FATTY-ACIDS AND BREAST-CANCER - IS THERE AN ASSOCIATION, American journal of epidemiology, 141(11), 1995, pp. 15-15
PHASE-II TRIAL OF MENOGARIL IN METASTATIC ADENOCARCINOMA OF THE PROSTATE
Authors: TAYLOR SA BLUMENSTEIN BA STEPHENS RL CRAWFORD ED PISTONE B HILL JB
Citation: Sa. Taylor et al., PHASE-II TRIAL OF MENOGARIL IN METASTATIC ADENOCARCINOMA OF THE PROSTATE, Investigational new drugs, 12(1), 1994, pp. 67-70
VERIFYING KEYED MEDICAL-RESEARCH DATA
Authors: BLUMENSTEIN BA
Citation: Ba. Blumenstein, VERIFYING KEYED MEDICAL-RESEARCH DATA, Statistics in medicine, 12(17), 1993, pp. 1535-1542
SOME STATISTICAL CONSIDERATIONS FOR THE INTERPRETATION OF TRIALS OF COMBINED ANDROGEN THERAPY
Authors: BLUMENSTEIN BA
Citation: Ba. Blumenstein, SOME STATISTICAL CONSIDERATIONS FOR THE INTERPRETATION OF TRIALS OF COMBINED ANDROGEN THERAPY, Cancer, 72(12), 1993, pp. 3834-3840
THE USE OF FLUTAMIDE IN HORMONE-REFRACTORY METASTATIC PROSTATE-CANCER
Authors: MCLEOD DG BENSON RC EISENBERGER MA CRAWFORD ED BLUMENSTEIN BA SPICER D SPAULDING JT
Citation: Dg. Mcleod et al., THE USE OF FLUTAMIDE IN HORMONE-REFRACTORY METASTATIC PROSTATE-CANCER, Cancer, 72(12), 1993, pp. 3870-3873
Risultati: 1-25 | 26-26